Companies / ORP

ORPHEUS URANIUM LIMITED

ASX:ORPMaterials

352.1M shares on issueASX (delayed) · as of 28 July 2026$0.090price · delayed$31.7Mmarket cap · indicative

Dilution grade

Share count grew 48% in 24 months; 3 cash raises in 24 months; runway 4–8 quarters

Cash runway6.0 quarters of funding

Share-count growth (24m)48.4%

Raise cadence (24m)3 cash raises

Options & rights overhang10.4% of shares

In-the-money supply3.8% of shares

Pending proposed issuesnone

ORPHEUS URANIUM LIMITED's ordinary share count grew 48.4% between December 2024 and February 2026, to 352M shares. The company raised capital three times in that 24-month window for total disclosed proceeds of A$7.3M, most recently raising A$4.4M in January 2026. Options and rights on issue could convert into 37M new shares, equal to 10.4% of the current share count, of which 4% are in the money at the current share price; the nearest expiry is November 2026. At the June 2026 quarter the company reported A$4.7M in cash, covering 6.0 quarters at the recent burn rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026

10.4%

Max option dilution

3.8%

ITM option dilution

Raises · last 12 months

6.0 qtrs

Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 352.1M per ASX (delayed) (28 July 2026).

Cash runway

6.0 qtrs

More than four quarters of funding at the recent spend rate.

$4.7M available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.

Paid plan

Cash runway history

Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.

Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	Total on issue after	Source
27 Apr 2026	3G · unquoted	ORP : ORDINARY FULLY PAID	352.1M	Appendix 3G
10 Feb 2026	2A · quoted issue	ORP : ORDINARY FULLY PAID	352.1M	Appendix 2A
9 Feb 2026	3G · unquoted	ORP : ORDINARY FULLY PAID	281.7M	Appendix 3G
20 Jan 2026	3G · unquoted	ORP : ORDINARY FULLY PAID	281.7M	Appendix 3G
11 Aug 2025	3H · cancellation	ORP : ORDINARY FULLY PAID	281.7M	Appendix 3H

Paid plan

Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Join the waitlist

Capital raises

3 cash raises in the last 24 months · 1 in the last 12 months

$4.4M

Capital raise

30 Jan 2026

Paid plan

Full raise history

Issue price, discount, brokers, purpose and tranche detail for every raise on record.

Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

10.4%

Total overhang · of current shares

3.8%

In the money · at current price

36.6M

Potential new shares

Nov 2026

Nearest expiry

Paid plan

Per-line options & expiry cliffs

Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.

Join the waitlist

Director dealings

Date	Director	Type	Shares	Options	Value	Source
20 Jan 2026	Clinton Dubieniecki	Other	8.0M	—	—	3Y notice
20 Jan 2026	Simon Mitchell	Other	500k	2.0M	—	3Y notice
20 Jan 2026	Todd Williams	Other	—	1.0M	—	3Y notice